Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.
Srikanthan P, Hevener AL, Karlamangla AS. · 2010
Read Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. by Srikanthan P, Hevener AL, Karlamangla AS. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3279294.txt.
Description
Preethi Srikanthan, Andrea Hevener, and Arun Karlamangla asked whether low muscle mass worsens the metabolic cost of obesity, in this 2010 analysis in PLoS ONE. Muscle loss, or sarcopenia, often accompanies obesity and could compound insulin resistance. Using a large United States health survey of more than fourteen thousand adults, they measured muscle by electrical impedance and related it to insulin resistance and blood sugar control.
Sarcopenia was tied to insulin resistance in both non-obese and obese people, independent of other factors. Among the obese, it was also tied to poorer blood sugar control, though not among the non-obese. The links ran strongest in people under sixty. Because the data are a snapshot, cause cannot be proven. Still, the authors suggest low muscle may be an early warning sign of diabetes risk. They urge work on preventing the sarcopenic-obese state.
Catalog record
| CREATOR | Srikanthan P, Hevener AL, Karlamangla AS. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |